Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers - Randomized, double blind, placebo-controlled study

Clinical Nutrition

Volumn 35, Issue 3, 2016, Pages 587-591

  Hojsak, Iva ^a   Močić Pavić, Ana ^a   Kos, Tea ^b   Dumančić, Jelena ^c   Kolaček, Sanja ^a,d  

^a Croatia   (Croatia)

^b Varazdin General Hospital   (Croatia)

^c Neuropsihijatrijska bolnica   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

BB 12 ; Children; Infection; Prevention; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ANGINA PECTORIS; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; BRONCHITIS; CHILD; COMMON COLD; CONTROLLED STUDY; DAY CARE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL INFECTION; HERPANGINA; HUMAN; INFECTION PREVENTION; INFLUENZA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OTITIS; PHARYNGITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINOPHARYNGITIS; SCARLET FEVER; CHILD NUTRITION; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; CROATIA; GASTROENTERITIS; IMMUNOLOGY; INCIDENCE; INFANT; INNATE IMMUNITY; MICROBIOLOGY; MULTICENTER STUDY; POISSON DISTRIBUTION; PRESCHOOL CHILD; RISK;

BIFIDOBACTERIUM ANIMALIS; CHILD; CHILD DAY CARE CENTERS; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROATIA; DOUBLE-BLIND METHOD; FEMALE; GASTROENTERITIS; HUMANS; IMMUNITY, INNATE; INCIDENCE; INFANT; INTENTION TO TREAT ANALYSIS; MALE; POISSON DISTRIBUTION; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; RISK;

EID: 84930026988     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.05.004     Document Type: Article

References (18)

1. Lu N., Samuels M.E., Shi L., Baker S.L., Glover S.H., Sanders J.M. Child day care risks of common infectious diseases revisited. Child Care Health Dev 2004, 30:361-368.
2. Silverstein M., Sales A.E., Koepsell T.D. Health care utilization and expenditures associated with child care attendance: a nationally representative sample. Pediatrics 2003, 111:e371-e375.
3. Cordell R.L., MacDonald J.K., Solomon S.L., Jackson L.A., Boase J. Illnesses and absence due to illness among children attending child care facilities in Seattle-King County, Washington. Pediatrics 1997, 100:850-855.
4. Dales R.E., Cakmak S., Brand K., Judek S. Respiratory illness in children attending daycare. Pediatr Pulmonol 2004, 38:64-69.
5. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Nase L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001, 322:1327.
6. Hojsak I., Snovak N., Abdovic S., Szajewska H., Misak Z., Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2010, 29:312-316.
7. Saavedra J.M., Abi-Hanna A., Moore N., Yolken R.H. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004, 79:261-267.
8. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
9. Lin J.S., Chiu Y.H., Lin N.T., Chu C.H., Huang K.C., Liao K.W., et al. Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine 2009, 27:1073-1079.
10. Merenstein D., Murphy M., Fokar A., Hernandez R.K., Park H., Nsouli H., et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 2010, 64:669-677.
11. Hao Q., Lu Z., Dong B.R., Huang C.Q., Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011, CD006895.
12. Taipale T., Pienihakkinen K., Isolauri E., Larsen C., Brockmann E., Alanen P., et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 2011, 105:409-416.
13. Floch M.H., Walker W.A., Madsen K., Sanders M.E., Macfarlane G.T., Flint H.J., et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011, 45:s168-s171.
14. Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr 2014, 58:531-539.
15. Hojsak I., Abdovic S., Szajewska H., Milosevic M., Krznaric Z., Kolacek S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010, 125:e1171-e1177.
16. Merenstein D.J., Smith K.H., Scriven M., Roberts R.F., Sanders M.E., Petterson S. The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. Eur J Clin Nutr 2010, 64:685-691.
17. Hidalgo-Cantabrana C., Sanchez B., Milani C., Ventura M., Margolles A., Ruas-Madiedo P. Genomic overview and biological functions of exopolysaccharide biosynthesis in bifidobacterium spp. Appl Environ Microbiol 2014, 80:9-18.
18. Gilad B., Svensson A.H., Viborg B., Stuer-Lauridsen, Jacobsen S. The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects. Proteomics 2011, 11:2503-2514.